title: [Outpatient management of patients with deep vein thrombosis and cancer: a study of safety, cost and budget impact].
abstract: OBJECTIVE
  This is a safety and cost comparison study with an analysis of budgetary impact of ambulatory management of patients with cancer and deep vein thrombosis (DVT) compared with hospital management.
  
  
  METHODS
  Prospective observational study of patients with known malignancy and diagnosed with DVT from 2003 to 2007. The outcome variables were mortality, relapse and bleeding in one month. We conducted an economic analysis to evaluate the comparative cost of ambulatory patients.
  
  
  RESULTS
  Three hundred and seventeen patients, 55 (17%) had cancer. The mean age of patients was 63 ± 11 years. There were 2 hemorrhagic events, 2 recurrences and 6 deaths in one month of follow-up. Of all patients, only 7 (13,7%) required hospitalization. All but one deaths were due to progression of the underlying disease. Economic analysis concluded that outpatient management is 6 times less expensive than hospital management, which would imply a cost reduction of 85%.
  
  
  CONCLUSIONS
  Specialized outpatient treatment of cancer patients with DVT is safe and could save significant financial resources.
authors.affiliation: Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Sevilla, España. luisoneumo@hotmail.com
authors.forename: Luis
authors.initials: L
authors.lastname: Jara Palomares
authors.forename: Candela
authors.initials: C
authors.lastname: Caballero Eraso
authors.forename: Teresa
authors.initials: T
authors.lastname: Elías Hernández
authors.forename: Marta
authors.initials: M
authors.lastname: Ferrer Galván
authors.forename: Sergio
authors.initials: S
authors.lastname: Márquez Peláez
authors.forename: Aurelio
authors.initials: A
authors.lastname: Cayuela
authors.forename: María José
authors.initials: MJ
authors.lastname: Alfaro
authors.forename: Emilia
authors.initials: E
authors.lastname: Barrot Cortés
authors.forename: Remedios
authors.initials: R
authors.lastname: Otero Candelera
mesh_terms: D000368:Aged; D000553:Ambulatory Care / Q000191:economics*; D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D002017:Budgets; D005260:Female; D005500:Follow-Up Studies; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006495:Heparin, Low-Molecular-Weight / Q000191:economics* / Q000627:therapeutic use; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000401:mortality; D011446:Prospective Studies; D013030:Spain; D015996:Survival Rate; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000191:economics / Q000209:etiology / Q000401:mortality
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight